News from Antibody Solutions

Antibody Solutions + Single Cell Technology, Inc. Partnership Expands Access to Single B-Cell Antibody Discovery
New offering aims to advance researchers’ ability to develop broader repertoire of novel antibody candidates Sunnyvale, Calif. (Dec. 4, 2017) – Antibody Solutions, a leader in discovery of therap... ...more, comments
Roche Acquires Adheron Therapeutics and Lead Asset, SDP051
Adheron Therapeutics has been acquired by Roche in a deal worth up to $580 million. The lead asset, SDP051, a humanized monoclonal antibody targeting Cadherin-11, has completed Phase 1 of clinical dev... ...more, comments
Abs to Difficult Membrane Proteins
"Antibody Development Strategies for Difficult Membrane Proteins" will be presented by Dr John Kenney at the Discovery On Target meeting in Boston, Sept. 24, 2015 at 12:50 PM, Westin Boston Waterfront... ...more, comments
AAPS-NBC 2015 Exhibit Hall Pass
We are exhibiting at the AAPS National Biotech Conference June 8th and 9th at the Marriott Marquis in San Francisco. See below for the registration link and Promo Code for a free one-day conference... ...more, comments
Antibody Solutions to Attend AAPS National Biotechnology Conference
Antibody Solutions will be attending the AAPS National Biotechnology Conference, June 8-10, 2015 at the San Francisco Marriott Marquis. ...more, comments


News-Medical.Net Antibodies News Feed

Latest Antibodies News and Research

Using a homemade, high-tech microscope, scientists at the University of Virginia School of Medicine have revealed how a cancer-causing virus anchors itself to our DNA. That discovery could pave the way for doctors to cure incurable diseases by flushing out viruses, including HPV and Epstein-Barr, that now permanently embed themselves in our cells.
Posted: April 20, 2018, 2:43 pm
A new blood test using gold nanoparticles could soon give oncologists an early and more accurate prognosis of how cancer treatment is progressing and help guide the on-going therapy of patients.
Posted: April 20, 2018, 10:20 am
Ten researchers at Karolinska Institutet have been awarded grants in the Swedish Childhood Cancer Foundation's latest call for funding, during which approximately SEK 62 million was allocated.
Posted: April 19, 2018, 7:42 am
Spending on cancer drugs in the United States has nearly doubled in the past five years and continues to grow, imposing substantial financial burden on patients with cancer.
Posted: April 19, 2018, 2:45 am
Quick, efficient pathogen detection and fingerprinting is essential and often lifesaving when it comes to preventing foodborne illness. Now, University of Georgia food scientist Xiangyu Deng has created a system that can identify foodborne pathogens in a fraction of the time taken by traditional methods.
Posted: April 18, 2018, 6:01 pm
Chronic lymphocytic leukemia is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream.
Posted: April 17, 2018, 10:24 pm
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced it has extended the manufacturing capability for its Lightning-Link technology, currently marketed under the Expedeon brand, to support scalability and bulk production of antibodies.
Posted: April 16, 2018, 1:29 pm
SYGNIS AG today announced the launch of its Universal Lateral Flow Assay kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Expedeon brand name.
Posted: April 16, 2018, 1:27 pm
Adora A. Lin, M.D., Ph.D., an attending physician in Children's department of Allergy and Immunology, was awarded $240,000 to improve understanding of how children's immune systems tolerate or react to certain food allergens--sometimes triggering a cascade of side effects that can be fatal.
Posted: April 14, 2018, 12:10 am
Wistar researchers have found that soluble antibodies promote tumor progression by inducing accumulation of myeloid-derived suppressor cells (MDSCs) in pre-clinical cancer models. Results were published online in Cancer Immunology Research.
Posted: April 13, 2018, 8:12 am